<!DOCTYPE html>
<html>

<head>
  <title>Survival Sample Size</title>
  <link rel="stylesheet" type="text/css" href="https://jKeeler-gce.github.io/style.css" />
  <script type="text/x-mathjax-config">
  MathJax.Hub.Config({tex2jax: {inlineMath: [['$','$'], ['\\(','\\)']]}});
</script>
<script type="text/javascript"
  src="http://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.1/MathJax.js?config=TeX-AMS-MML_HTMLorMML">
</script>
</head>

<body>

   <header>
     <h1> Sample Size Calculators </h1>
	 <a href="" target="" class="Bref">Home</a>
	 <a href="" target="" class="Bref2">Normal - Mean</a>
	 <a href="" target="" class="Bref2">Normal - Proportion</a>
	 <a href="" target="" class="Bref2">Cross-Over</a>
	 <a href="" target="" class="Bref2">Survival</a>
	 <a href="" target="" class="Bref2">Group Sequential</a>
	 <a href="" target="" class="Bref2">Formulas</a>
	 <a href="" target="" class="Bref2">References</a>
	 
   </header>
   
   <div class="rcorners1">
	   <h2> Formulas <h2>
   </div>
   <br>
   
  <div>
  
  <h3> Normally Distributed - Means </h3>

<p>
Using the definition of power:
</p> 

\[
    \mathbb{P}(\text{Reject} \; H_0 | H_1 \; \text{is true}) = 1 - \beta,
\]

<p>
the formula for the number of patients required can be obtained using:
</p>

\[
    n = \frac{1}{r(1-r)}\frac{\left(\Phi^{-1}\left(1-\alpha\right) + \Phi^{-1}\left(1-\beta\right)^2  \right)}{\Delta^2}\sigma^2,
\]

<p>
where:
</p>

<ul>
    <li> $\alpha$ is the Type I error. </li>
    <li> $\beta$ is the Type II error (or $1-\beta$ is the power). </li>
    <li> $r$ is the proportion of the treatment allocation allocated to the experimental treatment. </li>
    <li> $\Delta$ is the expected treatment effect. </li>
    <li> $\sigma$ is the standard deviation for the treatment effect </li>
</ul>

<h3> Crossover Trials - Differnece in Means </h3>

<p>
Using the work of Siyasinghe and Sooriyarachchi (2011), they consider the commonly used mixed effects model used for cross-over trials. Assuming this mixed effect model:
</p>

\[
    Y_{ijk} = \mu + t_k + p_i + s_{ijk} + e_{ijk},
\]

<p>
where:
</p>

<ul>
    <li> $Y_{ijk}$ is the response value of the $j^{\text{th}}$ subject result in the $i^{\text{th}}$ treatment period on the $k^{\text{th}}$ treatment. </li>
    <li> $t_k$ is the effect of $k^{\text{th}}$ treatment. </li>
    <li> $p_i$ is the effect of the $i^{\text{th}}$ period. </li>
    <li> $s_{ijk}$ is the random effect of the $j^{\text{th}}$ subject in the $i^{\text{th}}$ treatment period on the $k^{\text{th}}$ treatment. </li>
    <li> $e_{ijk}$ is the random error term. </li>
</ul>

<p>
If you let $\Delta$ be the expected treatment difference, then the required number of subjects can be calculated as:
</p>
\[
n = \frac{\left(\Phi^{-1}\left(1-\alpha\right) + \Phi^{-1}\left(1-\beta\right)^2  \right)}{2\Delta^2}\sigma^2,
\]
<p>
where the interpretations for $\alpha,\beta,\sigma$ are the same as the normally distributed case.
</p>

<h3> Survival Sample Size </h3>
<p>
For survival trials, the sample size calculations actually calculate the required number of events that need to be observed before analysis takes place, rather than the number of patients required. 

Using the formula from Schoenfeld (1983), the number of events required is:
</p>

\[
    d=\frac{1}{r(r-1)}\frac{\left(\Phi^{-1}\left(1-\alpha\right) + \Phi^{-1}\left(1-\beta\right)\right)^2}{\log^2(\Delta)},
\]

<p>
where all the values have the same interpretation as the normally distributes case, except $\Delta$, which is the expected hazard ratio. 

While the total number of people required doesn't effect the number of events (which means it doesnt effect the Type I error) it can be estimated. Using the methods of Julious (2009), first let;
</p>

\[
    \lambda_X = \frac{-\log(1-p_X)}{T},
\]
<p>
where:
</p>
<ul>
    <li> $\lambda_X$ is the exponential rate parameter for survival on treatment $X$. </li>
    <li> $p_X$ is the probability of observing an event on treatment $X$ </li>
    <li> $T$ is the 'time scale' the probability of observing an event is calculated over, for example, and annual death rate would mean $T=1$. </li>
</ul>

<p>
Using the expected number of events for treatment $X$:
</p>

\[
    \pi_X = \frac{\lambda_X}{\lambda_X + \nu}\left[ 1- \frac{e^{-F(\lambda_X + \nu)} \times \left( 1 - e^{-A(\lambda_X + \nu)}\right)}{A(\lambda_X + \nu)} \right],
\]

<p>
where:
</p>

<ul>
    <li> $\nu$ is the exponential drop out rate, calculated as $\nu = \frac{-\log(1-R)}{T}$, where $R$ is the probability of a drop out. </li>
    <li> $F$ is the follow up time (on the same scale as $T$). </li>
    <li> $A$ is the accrual rime (on the same scale as $T$). </li>
</ul>

<p>
Using this, the mean number of events for the trial can be calculated as:
</p>
\[
    \pi = \frac{1}{\left(\frac{1}{\pi_1}+\frac{1}{\pi_2}\right)},
\]

<p>
meaning the predicted total sample size, $N$ is;
</p>
\[
 N = \pi^{-1} \times d
\]

<h3> Group-Sequential Designs </h3>
<p>
For the group-sequntial calculation, the R package `gsDesign' was used. This package contains the methods of Pocock (1977) , O'Brien and Flemming (1979) and, Kim and Demets (1983). 
</p> 
   </div>

</body>

</html>
